MSCA Doctoral Network “LipiBRIGHT”: Doctoral Candidate position for Marie Skłodowska-Curie fellowship (m/f/d)

Key objectives are to provide:

1. Excellent scientific training on interdisciplinary level, covering liquid biochemistry and pathophysiology as well as clinical application.

2. Excellent complementary skills in personal and career development as well as business training required to extend beyond scientific research.

3. Exposure to both academic and non-academic environments, required to build bridges between researchers and entrepreneurs and support the future translation of research findings in innovative products and services.

LipidBRIGHT builds on available patient cohorts, advanced technologies and established cooperations and strives to synergistically improve structural training on European level. LipidBRIGHT will nurture the development of young, broadly-trained scientists able to successfully bridge clinical with basic research as well as academia and industry, which is a cornerstone in effectively combatting complex diseases as cardiovascular disease, chronic kidney disease, cancer and chronic inflammatory disease. Contributing partners in LipidBRIGHT: Universiteit Maastricht (NL), Catholic University KU Leuven (BE), University Hasselt (BE), University Hospital Jena (DE), INSERM (FR), University Utrecht (NL), SciCross (SE), RD –Néphrologie SAS (FR), University of Bern (CH).

For more information: One PhD (doctoral) position is available at the Department of Internal Medicine I, Laboratory for Lipid Metabolism, at Jena University Hospital. The project will run for 36 months. Supervisor: Prof. Dr. Paul Christian Schulze.

Titel: From Lipid-Associated Biomarkers to Novel Therapeutic Strategies in Cardiovascular Disease.

The doctoral candidate will focus on identifying and functionally characterising novel lipid-associated biomarkers in cardiovascular diseases. The aim is to gain a better understanding of disease-relevant signalling pathways and to derive innovative therapeutic strategies from this. The doctoral candidate will use modern molecular biological, cell biological and translational clinical methods to validate biomarkers in experimental models and patient samples. A particular focus is on linking omics-based analyses with functional studies to develop new targeted therapeutic approaches. Integration into the international LipiBRIGHT network enables structured, interdisciplinary training and close cooperation with leading European partner institutions.

Eligibility criteria:

According to the EU rules for the EU-Doctoral Network projects, the recruited researchers must comply with the following conditions:

are — at the date of recruitment — doctoral candidates (DCs) (i.e., may not have a doctoral degree).

DCs can be of any nationality.

DCs must comply with the following mobility rule: they must not have resided or carried out their main activity (work, studies, etc.) in the country of the recruiting beneficiary for more than 12 months in the 36 months immediately before their recruitment date. For beneficiaries that are international European interest organisations or international organisations: the DCs must not have spent in the same appointing organisation more than 12 months in the 3 years immediately before the recruitment date. Compulsory national service, short stays such as holidays and time spent by the researcher as part of a procedure for obtaining refugee status under the Geneva Convention are not considered.

Research Field/Requirements:

Ambitious, hard-working and accurate.

MSc degree in biology, biomedicine, biotechnology or natural sciences, biochemistry or comparable (before 01-09-2026).